| Literature DB >> 35935954 |
Ya-Fei Qin1,2, Shao-Hua Ren1,2, Bo Shao1,2, Hong Qin1,2, Hong-da Wang1,2, Guang-Ming Li1,2, Yang-Lin Zhu1,2, Cheng-Lu Sun1,2, Chuan Li1,2, Jing-Yi Zhang1,2, Hao Wang1,2.
Abstract
Background: IL-37 is a recently identified cytokine with potent immunosuppressive functions. The research fronts of IL-37 are worth investigating, and there is no bibliometric analysis in this field. The purpose of this study is to construct the intellectual base and predict research hotspots of IL-37 research both quantitatively and qualitatively according to bibliometric analysis.Entities:
Keywords: CiteSpace; IL-37; bibliometric analysis; immunity; visualization
Mesh:
Substances:
Year: 2022 PMID: 35935954 PMCID: PMC9354626 DOI: 10.3389/fimmu.2022.931783
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Figure 1Flowchart of the screening process.
Figure 2Annual publication growth trend of IL-37 research.
The top 10 countries/regions and institutions contributing to publications of IL-37 research.
| Rank | Country | Number of publications | Number of citations | Citations of per article | H-Index | Institutions | Article counts | Total number of citations | Average number of citations | Total number of first authors | Total number of first author citations | Average number of first author citations | Location | Centrality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CHINA | 257 | 2,709 | 16.22 | 33 | Univ Colorado Denver | 48 | 2,703 | 56.31 | 15 | 1,081 | 72.07 | USA | 0.11 |
| 2 | USA | 124 | 6,455 | 58.66 | 39 | Radboud Univ Nijmegen | 47 | 1,072 | 22.81 | 11 | 143 | 13 | NETHERLANDS | 0.11 |
| 3 | ITALY | 56 | 3,342 | 63.3 | 24 | Monash Univ | 43 | 2,150 | 50 | 5 | 39 | 7.8 | AUSTRALIA | 0.07 |
| 4 | NETHERLANDS | 46 | 3,261 | 75.35 | 23 | Fudan Univ | 39 | 255 | 6.54 | 14 | 91 | 6.5 | CHINA | 0.08 |
| 5 | GERMANY | 36 | 2,607 | 77.06 | 21 | Shandong Univ | 38 | 365 | 9.61 | 16 | 181 | 11.31 | CHINA | 0.04 |
| 6 | AUSTRALIA | 26 | 1,764 | 71.04 | 15 | Huazhong Univ Sci & Technol | 31 | 394 | 12.71 | 14 | 190 | 13.57 | CHINA | 0.20 |
| 7 | ENGLAND | 18 | 1,213 | 67.56 | 12 | Tufts Univ | 28 | 99 | 3.54 | 5 | 18 | 3.6 | USA | 0.01 |
| 8 | GREECE | 17 | 182 | 12.24 | 10 | Univ G dAnnunzio | 28 | 91 | 3.25 | 17 | 58 | 3.41 | SOUTH KOREA | 0.03 |
| 9 | IRAN | 16 | 135 | 8.75 | 8 | Guangdong Med Univ | 27 | 90 | 3.33 | 10 | 47 | 4.7 | CHINA | 0.01 |
| 10 | SOUTH KOREA | 15 | 847 | 58.4 | 10 | Shenzhen Univ | 25 | 780 | 31.2 | 10 | 272 | 27.2 | CHINA | 0.21 |
Figure 3The network map of collaboration between countries/regions.
The top 10 most productive journals and co-cited journals.
| Rank | Journals | Counts | Total number of citations | Average number of citations | IF and JCR division (2020) | Co-cited journals | Total number of co-citations | IF and JCR division (2020) | Centrality |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cytokine | 26 | 231 | 8.88 | 3.861, Q3 | Nature Immunology | 427 | 25.606, Q1 | 0.01 |
| 2 | Frontiers in Immunology | 21 | 70 | 3.33 | 7.561, Q1 | Journal of Immunology | 383 | 5.422, Q2 | 0.01 |
| 3 | Scientific Reports | 18 | 191 | 10.61 | 4.38, Q1 | PNAS | 383 | 11.205, Q1 | 0.02 |
| 4 | Mediators of Inflammation | 14 | 120 | 8.57 | 4.711, Q2 | Cytokine | 279 | 3.861, Q3 | 0.01 |
| 5 | PNAS | 13 | 726 | 55.85 | 11.205, Q1 | Plos One | 256 | 3.24, Q2 | 0.00 |
| 6 | International Immunopharmacology | 13 | 69 | 5.31 | 4.932, Q2 | Journal of Biological Chemistry | 222 | 5.157, Q2 | 0.01 |
| 7 | International Journal of Molecular Science | 10 | 29 | 2.9 | 5.924, Q1 | European Cytokine Network | 216 | 2.737, Q3 | 0.01 |
| 8 | Journal of Immunology | 7 | 351 | 50.14 | 5.422, Q2 | Immunity | 199 | 31.745, Q1 | 0.02 |
| 9 | Plos One | 7 | 94 | 13.43 | 3.24, Q2 | SCI REP-UK | 190 | 4.38, Q1 | 0.01 |
| 10 | Journal of Interferon and Cytokine Research | 7 | 68 | 9.71 | 2.607, Q3 | Clinical and Experimental Immunology | 186 | 4.33, Q2 | 0.03 |
Figure 4The dual-map overlay of journals.
The top 10 most productive authors and co-cited authors contributed to IL-37 research.
| Rank | Author | Article counts | Total number of citations | Average number of citations | First author counts | First author citation counts | Average first author citation counts | Corresponding author | Corresponding author citation counts | Centrality | Co-cited author | Citation counts | Centrality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dinarello, CA | 46 | 2,218 | 48.22 | 3 | 178 | 59.33 | 13 | 1,180 | 0.06 | Nold MF | 356 | 0.01 |
| 2 | Conti, P | 24 | 79 | 3.29 | 18 | 58 | 3.22 | 18 | 58 | 0.00 | Dinarello CA | 211 | 0.12 |
| 3 | Bufler, P | 20 | 1,718 | 85.9 | 1 | 100 | 100 | 6 | 302 | 0.01 | Boraschi D | 203 | 0.01 |
| 4 | Ronconi, G | 19 | 58 | 3.05 | 0 | 0 | 0 | 0 | 0 | 0.01 | McNamee EN | 179 | 0.02 |
| 5 | Caraffa, A | 18 | 58 | 3.22 | 0 | 0 | 0 | 0 | 0 | 0.00 | Nold-Petry CA | 154 | 0.00 |
| 6 | Kritas, SK | 16 | 50 | 3.13 | 0 | 0 | 0 | 0 | 0 | 0.00 | Kumar S | 154 | 0.04 |
| 7 | Nold, MF | 15 | 1,283 | 85.53 | 1 | 360 | 360 | 4 | 190 | 0.01 | Bufler P | 151 | 0.13 |
| 8 | Garlanda, C | 14 | 518 | 37 | 1 | 64 | 64 | 1 | 0 | 0.02 | Ye L | 145 | 0.00 |
| 9 | Theoharides, TC | 14 | 59 | 4.21 | 2 | 8 | 4 | 5 | 17 | 0.00 | Bulau AM | 142 | 0.08 |
| 10 | Huang, Z | 13 | 294 | 22.62 | 2 | 29 | 14.5 | 4 | 105 | 0.00 | Li SZ | 122 | 0.02 |
Figure 5The visualization of co-cited references on IL-37 research.
The top 10 co-cited references of IL-37 research.
| Rank | Title | Year | Author | Number of co-citations | Centrality |
|---|---|---|---|---|---|
| 1 | IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction | 2015 | Claudia A Nold-Petry | 117 | 0.01 |
| 2 | Extracellular forms of IL-37 inhibit innate inflammation | 2015 | Suzhao Li | 98 | 0.08 |
| 3 | Suppression of innate inflammation and immunity by interleukin-37 | 2016 | Charles A. Dinarello | 84 | 0.01 |
| 4 | IL-37 is a fundamental inhibitor of innate immunity | 2010 | Marcel F Nold | 83 | 0.09 |
| 5 | Suppression of inflammation and acquired immunity by IL-37 | 2017 | Giulio Cavalli | 77 | 0.06 |
| 6 | Suppression of antigen-specific adaptive immunity by IL-37 | 2014 | Yuchun Luo | 75 | 0.06 |
| 7 | Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses | 2014 | Ana-Maria Bulau | 74 | 0.09 |
| 8 | IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity | 2014 | Liang Ye | 74 | 0.00 |
| 9 | Interleukin 37 expression protects mice from colitis | 2011 | Eóin N. McNamee | 73 | 0.21 |
| 10 | IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation | 2015 | Liang Ye | 70 | 0.04 |
Figure 6(A) The clustered network map of co-cited references on IL-37 research. (B) The timeline view of co-citation clusters.
Temporal major clusters of co‐cited references.
| Cluster ID | Size | Silhouette | Mean (year) | Label (LSI) | Label (LLR) | Label (MI) |
|---|---|---|---|---|---|---|
| 0 | 124 | 0.784 | 2017 | cardiovascular diseases; human health | cardiovascular diseases; human health | IL-1f5; IFN-γ |
| 1 | 115 | 0.864 | 2013 | disease activity; potential role | disease activity; mast cell | IL-1f5; IFN-γ |
| 2 | 62 | 0.994 | 2007 | differential expression | differential expression | IL-1f5; IFN-γ |
| 3 | 60 | 0.922 | 2010 | new insight; IL-1 family member | new insight; interleukin-1 family | IL-1f5; IFN-γ |
| 4 | 49 | 0.992 | 2000 | IL-18 activity; complex | complex; IL-18 activity | disease activity; potential role |
| 5 | 47 | 0.932 | 2017 | IL-1 family cytokine; related cytokine | related cytokine; IL-1 family cytokine | IL-1f5; IFN-γ |
| 6 | 44 | 0.974 | 2016 | mast cell; inflammatory response | mast cell; key suppressor | allograft rejection; IL-1f5 |
| 7 | 34 | 0.913 | 2014 | disease pathogenesis; human aortic valve | disease pathogenesis; human aortic valve | cervical cancer; cell apoptosis |
| 8 | 32 | 0.969 | 2017 | IL-1 family; IL-1 family cytokine | epidermal barrier; therapeutic perspective | IL-1 inhibitor |
| 9 | 21 | 0.972 | 2004 | IL-1f5 mediates anti-inflammatory activity | IL-1f5; induction | disease activity; potential role |
Figure 7Top 25 references with the strongest citation bursts.
Figure 8(A) The co-occurrence map of keywords on IL-37 research. (B) Top 15 keywords with the strongest citation bursts.
The top 20 keywords of IL-37 research.
| Rank | Keywords | Counts | Centrality | Year | Rank | Keywords | Counts | Centrality | Year |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Expression | 165 | 0.02 | 2002 | 11 | NF-κb | 46 | 0.11 | 2002 |
| 2 | IL-37 | 165 | 0.14 | 2013 | 12 | Disease | 40 | 0.09 | 2014 |
| 3 | Inflammation | 134 | 0.15 | 2011 | 13 | Pathogenesis | 36 | 0.10 | 2013 |
| 4 | Cytokine | 117 | 0.07 | 2004 | 14 | T cell | 32 | 0.07 | 2004 |
| 5 | IL-1 family | 69 | 0.21 | 2003 | 15 | Member | 31 | 0.08 | 2002 |
| 6 | Cell | 66 | 0.08 | 2002 | 16 | Innate inflammation | 31 | 0.05 | 2017 |
| 7 | Immunity | 58 | 0.08 | 2011 | 17 | Inhibitor | 29 | 0.10 | 2001 |
| 8 | Receptor | 54 | 0.10 | 2004 | 18 | IL-18Rα | 29 | 0.05 | 2016 |
| 9 | Rheumatoid arthritis | 54 | 0.06 | 2013 | 19 | Dendritic cell | 27 | 0.14 | 2012 |
| 10 | Activation | 52 | 0.08 | 2002 | 20 | Suppression | 27 | 0.02 | 2018 |
Top 20 subject categories of IL-37 research.
| Rank | Web of Science categories | Quantity | Percentage |
|---|---|---|---|
| 1 | Immunology | 200 | 37.453 |
| 2 | Cell Biology | 108 | 20.225 |
| 3 | Biochemistry Molecular Biology | 90 | 16.854 |
| 4 | Medicine Research Experimental | 52 | 9.738 |
| 5 | Multidisciplinary Sciences | 44 | 8.24 |
| 6 | Pharmacology Pharmacy | 39 | 7.303 |
| 7 | Oncology | 37 | 6.929 |
| 8 | Rheumatology | 22 | 4.12 |
| 9 | Allergy | 19 | 3.558 |
| 10 | Medicine General Internal | 15 | 2.809 |
| 11 | Chemistry Multidisciplinary | 13 | 2.434 |
| 12 | Endocrinology Metabolism | 13 | 2.434 |
| 13 | Dermatology | 12 | 2.247 |
| 14 | Biotechnology Applied Microbiology | 11 | 2.06 |
| 15 | Microbiology | 11 | 2.06 |
| 16 | Pathology | 10 | 1.873 |
| 17 | Genetics Heredity | 9 | 1.685 |
| 18 | Cardiac Cardiovascular Systems | 8 | 1.498 |
| 19 | Gastroenterology Hepatology | 8 | 1.498 |
| 20 | Hematology | 8 | 1.498 |